Colma, CA, United States of America

Ryan Keith Muir

This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryan Keith Muir. Retrieved from https://idiyas.com/inventor/ryan-keith-muir

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ryan Keith Muir

Introduction

Ryan Keith Muir is a notable inventor based in Colma, California. He has made significant contributions to the field of medical science through his innovative work. With a total of 2 patents, Muir is recognized for his advancements in trioxolane compounds.

Latest Patents

Muir's latest patents focus on trioxolane agents. These patents disclose various trioxolane compounds and methods for their use in the treatment and detection of diseases. His research aims to enhance medical treatments and improve disease detection methods.

Career Highlights

Muir is affiliated with the University of California, where he continues to push the boundaries of scientific research. His work has garnered attention for its potential impact on healthcare and disease management.

Collaborations

Muir collaborates with esteemed colleagues such as Adam Renslo and Brian Richard Blank. Together, they contribute to the advancement of medical research and innovation.

Conclusion

Ryan Keith Muir's contributions to the field of medical science through his patents and collaborations highlight his role as an influential inventor. His work in trioxolane compounds is paving the way for future advancements in disease treatment and detection.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…